Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors

European Journal of Pharmacology
G NowakPiotr Popik

Abstract

Glycine displaces [3H]CGP-39653 ([3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) binding to the glutamate recognition site with both high and low affinity. We reported previously that chronic treatment with antidepressants reduced the proportion of high to low affinity sites, or, even eliminated the high affinity sites in case of citalopram. Here, we compared the effects of citalopram with another serotonin specific reuptake inhibitor, fluoxetine on this measure. Chronic administration of citalopram or fluoxetine eliminated high affinity glycine-displaceable [3H]CGP-39653 binding to the mouse cortex in 78 and 56% of animals, respectively, indicating that selective serotonin reuptake inhibitors produce qualitatively similar adaptive changes at NMDA receptors, that differ from other antidepressants in this neurochemical measure.

References

Oct 1, 1993·Journal of Neurochemistry·M MugnainiF T van Amsterdam
Jan 4, 1996·European Journal of Pharmacology·G NowakI A Paul
Apr 1, 1997·Journal of Clinical Psychopharmacology·R I ShaderD J Greenblatt

❮ Previous
Next ❯

Citations

Apr 21, 2007·Journal of Neural Transmission·E Poleszak
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Asher B Simon, Jack M Gorman
Jan 16, 2004·Pharmacology, Biochemistry, and Behavior·C M Padovan, F S Guimarães
Mar 30, 1999·Brain Research·E F BastosC A Serfaty
Jan 29, 2002·Pharmacology, Biochemistry, and Behavior·A YilmazR Canbeyli
Dec 13, 2000·Brain Research. Brain Research Reviews·D O Frost, J L Cadet
Apr 22, 2008·Nature Reviews. Drug Discovery·Gerard SanacoraHusseini K Manji
May 28, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Beata KarolewiczGregory A Ordway
Apr 29, 2014·Pharmacology, Biochemistry, and Behavior·Fabiana K LudkaCarla I Tasca
Jun 21, 2011·Expert Opinion on Investigational Drugs·Jolanda PrinsS Mechiel Korte
Jan 3, 2016·Progress in Neurobiology·Rodrigo Machado-VieiraCarlos A Zarate
Feb 29, 2016·Pharmacological Reports : PR·Karolina PytkaBarbara Filipek
Sep 15, 2014·Neuroscience and Biobehavioral Reviews·Mehdi GhasemiAhmad Salehi
May 21, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·C J McGinnityJ S Duncan
Jan 2, 2003·Nutritional Neuroscience·H Murck
Dec 20, 2003·Annals of the New York Academy of Sciences·Ian A Paul, Phil Skolnick
Nov 17, 2006·Expert Opinion on Investigational Drugs·Agnieszka Palucha
Jan 7, 2015·Pharmacological Reports : PR·Krystyna Cegielska-PerunMagdalena Bujalska-Zadrożny
Dec 4, 2014·Psychiatry Research·Arpan DuttaJ F William Deakin
Mar 8, 2005·Journal of Pharmacological Sciences·Jordanna E Bermack, Guy Debonnel
Jun 22, 2007·Pharmacology & Therapeutics·Agnieszka Palucha, Andrzej Pilc
Oct 2, 2003·Journal of Clinical Psychopharmacology·Terence A KetterRobert M Post
May 23, 2006·Pharmacological Reviews·Maurizio Raiteri
Oct 3, 1999·Journal of Clinical Psychopharmacology·P Popik
Oct 31, 2002·Human Psychopharmacology·Ian A Paul

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.